Non-Invasive Prenatal Testing Market(NIPT) by Country (Actual and Potential), Test Outlook, Deals Type, Growth, Share, Opportunities and Forecast to 2021
Date: Apr-2016 | Id: MACRC-0036 | Geographical Scope: Global | Publisher: DPI Research
The global NIPT test market accounted for US$ XX Million in 2015 and is expected to reach US$ XX Million in 2016 and US$ XX Million by 2021, growing at a CAGR of XX% during the forecast period. Market growth can be attributed to factors such as high incidence rate of babies born with Down syndrome, no risk of miscarriage with NIPT and shifting trend towards child bearing at advanced maternal age (35 years or older). With increased patient access to NIPT test, the NIPT market is anticipated to have a positive outlook in the coming years. High test cost, strict regulatory requirements and ethical hurdles is restraining the growth of NIPT test market. United States is seen as the dominant player in the NIPT test market followed by Germany, China and India in 2015. In the coming years, NIPT test market is expected to witness the highest growth rate in the Asian region, with emphasis on China and India. These countries are expected to increase revenues for the manufacturers of tests involved in NIPT test market. On the basis of test, MaterniT21 plus test has gain its momentum in 2011 when there was only one NIPT test available in the market. MaterniT21 test market revenue value was US$ XX Million in 2015. It is expected that MaterniT21 plus test will lead the NIPT test market with the market share of more than XX% by the year 2021. Other NIPT tests such as Panorama, Harmony, Verifi, NIFTY and Prerna test have emerged as the promising test in the NIPT test market. The major companies are expanding their tests through collaboration, distribution agreement, strategic alliances and partnerships with clinical laboratories and hospitals. The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry–validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market segments, country wise actual and potential market, NIPT test analysis with volume and market revenue and competitive landscape. The report also covers market growth drivers, challenges, current and upcoming trends of the NIPT test market GLOBAL NON-INVASIVE PRENATAL TESTING (NIPT) MARKET SEGMENTATION Global Non-Invasive Prenatal Testing (NIPT) Market – By Test Type 1. MaterniT21 PLUS 2. Harmony 3. NIFTY 4. Verifi 5. Panorama 6. PrenaTest 7. BambniTest 8. informaSeq 9. VisibiliT 10. Veracity 11. IONA Test Global Non-Invasive Prenatal Testing (NIPT) Market – By Country 1. United States 2. United Kingdom 3. Germany 4. Italy 5. Spain 6. France 7. Switzerland 8. Sweden 9. Belgium 10. Australia 11. New Zealand 12. Japan 13. China 14. India 15. Brazil
Table of Contents 1. Executive Summary 2. Global Non–Invasive Prenatal Testing(NIPT)Market Analysis (2011 – 2021) 2.1 By Country – Overall NIPT Test Volume, Actual & Potential Market Outlook 2.1.1 By Country – NIPT Test Volume Outlook 2.1.2 By Country – NIPT Test Actual Market Outlook 2.1.3 By Country – NIPT Test Potential Market Outlook 2.2 By Test – Overall NIPT Test Volume & Market Outlook 2.2.1 NIPT Test Volume Outlook 2.2.2 NIPT Test Market Revenue Outlook 3. Global Non–Invasive Prenatal Testing(NIPT) Market Share Analysis (2011 – 2021) 3.1 By Country – NIPT Test Volume, Actual & Potential Market Share 3.1.1 By Country – NIPT Test Volume Share 3.1.2 By Country – NIPT Test Actual Market Share 3.1.3 By Country – NIPT Test Potential Market Share 3.2 By Test – NIPT Test Volume & Market Share 3.2.1 NIPT Test Volume Share 3.2.2 NIPT Test Market Share 4. Global Non–Invasive Prenatal Testing(NIPT) Market – Geographical Segment (2013 – 2021) 4.1 United States 4.1.1 United States – NIPT Test Volume & Forecast 4.1.2 United States – Actual NIPT Test Market & Forecast 4.1.3 United States – Potential NIPT Test Market & Forecast 4.2 United Kingdom 4.2.1 United Kingdom – NIPT Test Volume & Forecast 4.2.2 United Kingdom – Actual NIPT Test Market & Forecast 4.2.3 United Kingdom – Potential NIPT Test Market & Forecast 4.3 Germany 4.3.1 Germany – NIPT Test Volume & Forecast 4.3.2 Germany – Actual NIPT Test Market & Forecast 4.3.3 Germany – Potential NIPT Test Market & Forecast 4.4 Italy 4.4.1 Italy – NIPT Test Volume & Forecast 4.4.2 Italy – Actual NIPT Test Market & Forecast 4.4.3 Italy – Potential NIPT Test Market & Forecast 4.5 Spain 4.5.1 Spain – NIPT Test Volume & Forecast 4.5.2 Spain – Actual NIPT Test Market & Forecast 4.5.3 Spain – Potential NIPT Test Market & Forecast 4.6 France 4.6.1 France – NIPT Test Volume & Forecast 4.6.2 France – Actual NIPT Test Market & Forecast 4.6.3 France – Potential NIPT Test Market & Forecast 4.7 Switzerland 4.7.1 Switzerland – NIPT Test Volume & Forecast 4.7.2 Switzerland – Actual NIPT Test Market & Forecast 4.7.3 Switzerland – Potential NIPT Test Market & Forecast 4.8 Sweden 4.8.1 Sweden – NIPT Test Volume & Forecast 4.8.2 Sweden – Actual NIPT Test Market & Forecast 4.8.3 Sweden – Potential NIPT Test Market & Forecast 4.9 Belgium 4.9.1 Belgium – NIPT Test Volume & Forecast 4.9.2 Belgium – Actual NIPT Test Market & Forecast 4.9.3 Belgium – Potential NIPT Test Market & Forecast 4.10 Australia 4.10.1 Australia – NIPT Test Volume & Forecast 4.10.2 Australia – Actual NIPT Test Market & Forecast 4.10.3 Australia – Potential NIPT Test Market & Forecast 4.11 New Zealand 4.11.1 New Zealand – NIPT Test Volume & Forecast 4.11.2 New Zealand – Actual NIPT Test Market & Forecast 4.11.3 New Zealand – Potential NIPT Test Market & Forecast 4.12 Japan 4.12.1 Japan – NIPT Test Volume & Forecast 4.12.2 Japan – Actual NIPT Test Market & Forecast 4.12.3 Japan – Potential NIPT Test Market & Forecast 4.13 China 4.13.1 China – NIPT Test Volume & Forecast 4.13.2 China – Actual NIPT Test Market & Forecast 4.13.3 China – Potential NIPT Test Market & Forecast 4.14 India 4.14.1 India – NIPT Test Volume & Forecast 4.14.2 India – Actual NIPT Test Market & Forecast 4.14.3 India – Potential NIPT Test Market & Forecast 4.15 Brazil 4.15.1 Brazil – NIPT Test Volume & Forecast 4.15.2 Brazil – Actual NIPT Test Market & Forecast 4.15.3 Brazil – Potential NIPT Test Market & Forecast 5. Global Non–Invasive Prenatal Testing(NIPT) Market – By Test (2011 – 2021) 5.1 Panorama Test 5.1.1 Global – Panorama Prenatal Test Volume & Forecast 5.1.2 Global – Panorama Prenatal Test Market Revenue & Forecast 5.2 Non–Invasive Fetal Trisomy (NIFTY) Test 5.2.1 Global – NIFTY Test Volume & Forecast 5.2.2 Global – NIFTY Test Market Revenue & Forecast 5.3 MaterniT21 PLUS Test 5.3.1 Global – MaterniT21 PLUS Test Volume & Forecast 5.3.2 Global – MaterniT21 PLUS Test Market Revenue & Forecast 5.4 Harmony Prenatal Test 5.4.1 Global – Harmony Prenatal Test Volume & Forecast 5.4.2 Global – Harmony Prenatal Test Market Revenue & Forecast 5.5 Bambini Test 5.5.1 Global – Bambini Test Volume & Forecast 5.5.2 Global – Bambini Test Market Revenue & Forecast 5.6 Verifi Prenatal Test 5.6.1 Global – Verifi Prenatal Test Volume & Forecast 5.6.2 Global – Verifi Prenatal Test Market Revenue & Forecast 5.7 Prena Test 5.7.1 Global – Prena Test Volume & Forecast 5.7.2 Global – Prena Test Market Revenue & Forecast 5.8 VisibiliT Test 5.8.1 Global – VisibiliT Test Volume & Forecast 5.8.2 Global – VisibiliT Test Market Revenue & Forecast 5.9 informaSeq Test 5.9.1 Global – InformaSeq Test Volume & Forecast 5.9.2 Global – informaSeq Test Market Revenue & Forecast 5.10 Veracity Test 5.10.1 Global – Veracity Test Volume & Forecast 5.10.2 Global – Veracity Test Market Revenue & Forecast 5.11 IONA Test 5.11.1 Global – IONA Test Volume & Forecast 5.11.2 Global – IONA Test Market Revenue & Forecast 6. Competitive Landscape 6.1 Non–Invasive Prenatal Testing(NIPT) – Comparative Analysis 6.2 Non–Invasive Prenatal Testing – Collaboration Deals 6.2.1 Year 2007 6.2.2 Year 2013 6.2.3 Year 2014 6.2.4 Year 2015 6.3 Non–Invasive Prenatal Testing – Venture Capital Investment 6.3.1 Year 2011 6.3.2 Year 2012 6.3.3 Year 2013 6.3.4 Year 2015 6.4 Non–Invasive Prenatal Testing – Merger and Acquisition 6.4.1 Year 2013 6.4.2 Year 2014 6.4.3 Year 2016 6.5 Non–Invasive Prenatal Testing – Exclusive Agreement 6.5.1 Year 2008 6.5.2 Year 2013 6.5.3 Year 2014 6.5.4 Year 2015 6.5.5 Year 2016 6.6 Non–Invasive Prenatal Testing – Licensing Agreement 6.6.1 Year 2007 6.6.2 Year 2011 6.6.3 Year 2013 6.6.4 Year 2014 6.6.5 Year 2015 6.6.6 Year 2016 6.7 Non–Invasive Prenatal Testing – Distribution Agreement 6.7.1 Year 2012 6.7.2 Year 2013 6.7.3 Year 2014 6.7.4 Year 2015 6.7.5 Year 2016 6.8 Non–Invasive Prenatal Testing – Partnership Deals 6.8.1 Year 2012 6.8.2 Year 2013 6.8.3 Year 2014 6.8.4 Year 2015 6.8.5 Year 2016 7. Non–Invasive Prenatal Testing (NIPT) Implementation 7.1 Non–Invasive Prenatal Testing (NIPT) Implementation – High–Income Countries 7.1.1 Clinical Issues 7.1.2 Ethical Issues 7.1.3 Legal and Regulatory Issues 7.2 Non–Invasive Prenatal Testing (NIPT) Implementation – Low – or–Middle Income Countries 7.2.1 Clinical Issues 7.2.2 Ethical Issues 7.2.3 Legal and Regulatory Issues 8. Global Non–Invasive Prenatal Testing Market – Growth Drivers 9. Global Non–Invasive Prenatal Testing Market – Challenges
Related reports
Global IVD Market
$2640-$4521
Pediatric Interventional Cardiology Market
$2640-$4521